Comparison of Alpha-fetoprotein-positive and AFP-negative patients with advanced gastroesophageal junction or gastric cancer receiving immunotherapy: an analysis stratified by HER2 status
AFP positivity may indicate inferior efficacy of first-line chemo-immunotherapy in HER2-negative advanced GEJ/GC, and anti-angiogenic therapy warrants further evaluation as a potential strategy to improve outcomes.
Authors
- Huizhen Liu (ORCID: https://orcid.org/0009-0004-7214-4211)
Institutions
- Ministry of Education (ET)
Publication Details
- Journal
- American Journal of Cancer Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.62347/oxuz2453
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00